BRAF mutation testing in melanoma: results from a German observational multicenter study

Area of Science:

• Oncology
• Molecular Diagnostics
• Pathology

Background:

• Accurate BRAF mutation testing is vital for melanoma treatment selection.
• Routine testing quality control is essential in clinical practice.

Purpose of the Study:

• To assess the influence of patient and sample characteristics on BRAF mutation testing results in melanoma patients.
• To develop a predictive model for BRAF mutation rates based on clinical data.

Main Methods:

• Prospective study analyzing data from 642 melanoma patients across 28 German pathology centers.
• Collected data included patient demographics, melanoma characteristics, and tissue quality.
• Multiple logistic regression and predictive modeling were used to analyze BRAF mutation rates.

Main Results:

• BRAF mutations were found in 37.5% of analyzed patients (241/642).
• Patient age, origin of sample (including metastasis location), and tissue quality were significant predictors of BRAF mutation status.
• Initial analysis showed testing method influenced results, but this became non-significant after excluding centers with data discrepancies.

Conclusions:

• Patient and sample characteristics, not solely the testing method, are key determinants of BRAF mutation detection rates.
• A validated predictive model could enable pathology centers to benchmark their BRAF testing performance.
• This approach supports improved quality control and standardization in molecular diagnostics for melanoma.